Friday, July 10, 2026

Drug profile · INN

amphetamine resin complex

amphetamine resin complex (BIPHETAMINE 7.5) is a dopamine transporter releasing agent. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — amphetamine resin complex
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

amphetamine resin complex (BIPHETAMINE 7.5) is a dopamine transporter releasing agent. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN amphetamine resin complex
Brand BIPHETAMINE 7.5
Mechanism Dopamine transporter releasing agent
Target Sodium-dependent dopamine transporter
Route ORAL
Formulation CAPSULE, EXTENDED RELEASE

Mechanism of action

Dopamine transporter releasing agent

Primary target: Sodium-dependent dopamine transporter

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. amphetamine adipate Dopamine transporter releasing agent
  2. amphetamine aspartate Norepinephrine transporter releasing agent
  3. amphetamine sulfate Norepinephrine transporter releasing agent
  4. armodafinil Dopamine transporter inhibitor
  5. bupropion hydrochloride Dopamine transporter inhibitor
  6. dexmethylphenidate hydrochloride Norepinephrine transporter inhibitor

Frequently asked questions

What is amphetamine resin complex?

amphetamine resin complex (BIPHETAMINE 7.5) is a dopamine transporter releasing agent. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for amphetamine resin complex?

BIPHETAMINE 7.5 is a marketed brand name for amphetamine resin complex. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of amphetamine resin complex?

amphetamine resin complex has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.